Regulatory

Regulatory

Medicare program; Meeting announcement for the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests

LABline

April 18, 2024

A Notice by the Centers for Medicare & Medicaid Services on April 16, 2024.

Regulatory

Final Rule- CLIA Fees, histocompatibility, personnel, and alternative sanctions for Certificate of Waiver laboratories (CMS-3326-F)

LABline

April 16, 2024

Regulatory

Recent prosecutions of clinical labs for fraud: Practices to avoid

Shelley Slade, Esq

April 12, 2024

Regulatory

The Clinical and Laboratory Standards Institute announces the publication of new antimicrobial susceptibility testing documents CLSI M100-Ed34, M02-Ed14, and M07-Ed12

LABline

April 11, 2024

Regulatory

New updated CLSI AST guidance

LABline

March 26, 2024

Regulatory

Announcement of the re-approval of COLA under the Clinical Laboratory Improvement Amendments of 1988

LABline

March 8, 2024

Regulatory

Meeting of the Clinical Laboratory Improvement Advisory Committee

LABline

March 5, 2024

Notice of meeting.

Regulatory

CMS releases vaccine toolkit of vaccine coverage and administration for Medicaid and Children’s Health Insurance Program individuals

LABline

Feb. 26, 2024

CMS summary.

Regulatory

HHS Office for Civil Rights delivers annual Reports to Congress on HIPAA compliance and breaches of unsecured protected health information

LABline

Feb. 23, 2024

Reports highlight for regulated entities where to focus HIPAA compliance efforts.

Regulatory

CMS issues additional guidance on program to allow people with Medicare to pay out-of-pocket prescription drug costs in monthly payments

LABline

Feb. 20, 2024

The Inflation Reduction Act’s Medicare Prescription Payment Plan will allow people to pay Medicare Part D out-of-pocket costs over the course of the year starting in 2025.

Regulatory

Medicare program; Strengthening oversight of accrediting organizations (AOs) and preventing AO conflict of interest, and related provisions

LABline

Feb. 15, 2024

This document has a comment period that ends in 60 days.

Regulatory

HHS releases 2023 update to Equity Action Plan

LABline

Feb. 14, 2024

Outlines new commitments to advance equity.

Regulatory

Accrediting organization proposed rule fact sheet

LABline

Feb. 13, 2024

Strengthening CMS oversight of accrediting organizations.

Regulatory

HHS expands TEFCA by adding two additional QHINs

LABline

Feb. 13, 2024

Seven QHINs will now safely and securely exchange critical health information for patient care.

Regulatory

Texting of Patient Information and Orders for Hospitals and CAHs

LABline

Feb. 9, 2024

CMS memo.

Regulatory

HHS finalizes new provisions to enhance integrated care and confidentiality for patients with substance use conditions

LABline

Feb. 9, 2024

Final rule to implement the bipartisan CARES Act legislation.

Regulatory

Regulatory

HRSA takes new steps to transform the organ transplant system

LABline

Feb. 6, 2024

Regulatory

34th edition of Standards for Blood Banks and Transfusion Services takes effect April 1

LABline

Feb. 5, 2024

Regulatory

CMS releases proposed payment updates for 2025 Medicare Advantage and Part D programs

LABline

Feb. 2, 2024

Regulatory

FDA and CMS: Americans deserve accurate and reliable diagnostic tests, wherever they are made

LABline

Jan. 19, 2024

Regulatory

HHS launches new Medicaid/CHIP resource hub to help keep people covered

LABline

Jan. 16, 2024

Regulatory

CLSI introduces country-based pricing to increase global access to laboratory standards

LABline

Jan. 12, 2024

Regulatory

Comments to shape updates to PBM, perioperative standards due Jan. 17

LABline

Jan. 9, 2024